Immediate and Long-Term Safety of Recombinant Adeno-associated Virus Injection into the Nonhuman Primate Muscle

This publication has 30 references indexed in Scilit:

• Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectors
  Gene Therapy, 2001
• Safety of Adeno-Associated Virus as Cochlear Gene Transfer Vector: Analysis of Distant Spread Beyond Injected Cochleae
  Molecular Therapy, 2000
• Hyaluronidase enhances recombinant adeno-associated virus (rAAV)-mediated gene transfer in the rat skeletal muscle
  Gene Therapy, 2000
• Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector
  Nature Genetics, 2000
• The Use of Adeno-Associated Virus to Circumvent the Maturation-Dependent Viral Transduction of Muscle Fibers
  Human Gene Therapy, 2000
• Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield
  Gene Therapy, 1999
• Factors Influencing Recombinant Adeno-Associated Virus Production
  Human Gene Therapy, 1998
• Aerosol-Mediated Delivery of Recombinant Adenovirus to the Airways of Nonhuman Primates
  Human Gene Therapy, 1995
• Detection of adeno-associated virus type 2 in human peripheral blood cells
  Journal of General Virology, 1992
• Efficient selection for high-expression transfectants with a novel eukaryotic vector
  Gene, 1991